U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07089823) titled 'A Study of YP05002 in Healthy Participants' on July 25.
Brief Summary: This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, efficacy, food effect of YP05002 Tablets in healthy participants
Study Start Date: Aug. 19
Study Type: INTERVENTIONAL
Condition:
Weight Management
Intervention:
DRUG: YP05002
Tablet, QD
OTHER: Placebo
Tablet, QD
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Yaopharma Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....